Actively Recruiting
CONDUIT™ Anterior Lumbar Interbody Fusion (ALIF) Cage System in Lumbar Degenerative Disease
Led by University College Dublin · Updated on 2025-04-23
35
Participants Needed
1
Research Sites
183 weeks
Total Duration
On this page
Sponsors
U
University College Dublin
Lead Sponsor
M
Mater Misericordiae University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This will be a prospective, multi-centre study at a National Tertiary Referral Centre for spinal trauma and spinal cord injuries, serving a catchment area of 5 million people. This study will follow patients undergoing anterior lumbar interbody fusion (ALIF) procedure. This trial seeks to evaluate the performance of this CE-marked device, and to assess outcomes in frail and non-frail patient cohorts. The CONDUIT™ ALIF Cage System are intervertebral body fusion devices intended for use for anterior lumbar interbody fusion in skeletally mature patients. The devices are 3D printed cellular titanium implants that feature 80% porous macro-, micro- and nanostructures, are designed to mimic cortical and cancellous bone, and facilitate fusion. This pilot study hypothesizes that the use of CONDUIT ALIF Cage system to treat lumbar degenerative disc disease will achieve results comparable to historical cases using SYNFIX Systems.
CONDITIONS
Official Title
CONDUIT™ Anterior Lumbar Interbody Fusion (ALIF) Cage System in Lumbar Degenerative Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 65 18 years old
- Consenting patients undergoing anterior lumbar interbody fusion (ALIF) procedure for whom the CONDUIT cage system is appropriate
You will not qualify if you...
- Patients under 18 years of age
- Non-surgical candidates or those with contraindications to surgery such as medical comorbidities, known infection, or pregnancy
- Patients with established osteoporosis
- Long-term, systemic steroid use
- Systemic diseases like rheumatoid arthritis, AIDS, or HIV
- Patients unwilling or unable to give informed consent or complete health-related quality of life outcome measures at specified times
- History of drug or alcohol use that may interfere with study adherence
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mater Misericordiae University Hospital
Dublin, Leinster, Ireland, D07R2WY
Actively Recruiting
Research Team
J
Jake McDonnell, MRCS
CONTACT
J
Joseph Butler, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here